Cargando…
The role of JMJD6/U2AF65/AR-V7 axis in castration-resistant prostate cancer progression
Castration-resistant prostate cancer (CRPC) remains prostate cancer research and treatment bottleneck. Abnormal androgen receptor (AR) activation still has a pivotal role in CRPC. Multiple mechanisms involve the process, of which overabundant AR-V7 mRNA splicing production is currently focused and i...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802141/ https://www.ncbi.nlm.nih.gov/pubmed/33430885 http://dx.doi.org/10.1186/s12935-020-01739-1 |